Literature DB >> 21128326

Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran.

Shohreh Farshad1, Abdolvahab Alborzi, Aziz Japoni, Reza Ranjbar, Kazem Hosseini Asl, Parisa Badiee, Maneli Amin Shahidi, Marziyeh Hosseini.   

Abstract

AIM: To improve our understanding of Iranian regional variation in Helicobacter pylori (H. pylori) antibiotic resistance rates to find the best antibiotic therapy for eradication of H. pylori infections.
METHODS: A total of 266 patients undergoing endoscopy in Shiraz, Southern Iran, were included in this study. H. pylori strains were isolated from antral biopsies by culture and confirmed by the rapid urease-test and gram staining. Antibiotic susceptibility of H. pylori isolates was determined by E-test.
RESULTS: A total of 121 H. pylori strains were isolated, 50 from male and 71 from female patients. Data showed that 44% (n = 53), 20% (n = 24), 5% (n = 6), and 3% (n = 4) of all strains were resistant to the antibiotics metronidazole, amoxicillin, clarithromycin, and tetracycline, respectively. When the antibiotics were considered together we found 11 sensitivity patterns for the strains. Resistance to metronidazole was significantly higher in female than in male patients (P < 0.05). In about 71% of the metronidazole-resistant isolates, the minimum inhibitory concentrations (MICs) exceeded 256 μg/mL.
CONCLUSION: We found a moderate rate of primary resistance to metronidazole. However, a high MIC (> 256 mg/L) which was found in 71% of the isolates is considerable. In the case of amoxicillin, an increased resistance rate of 20% is worrying. Resistance to clarithromycin and tetracycline is also emerging among the H. pylori strains in our region.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21128326      PMCID: PMC2997992          DOI: 10.3748/wjg.v16.i45.5746

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  42 in total

1.  Antibiotic resistance in Helicobacter pylori.

Authors:  L Teare; T Peters; S Saverymuttu; R Owen; I Tiwari
Journal:  Lancet       Date:  1999-01-16       Impact factor: 79.321

2.  Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents.

Authors:  R Piccolomini; G Di Bonaventura; G Catamo; F Carbone; M Neri
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

Review 3.  Resistance of Helicobacter pylori to antibiotics.

Authors:  F Mégraud
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

4.  Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori.

Authors:  Y J Debets-Ossenkopp; M Sparrius; J G Kusters; J J Kolkman; C M Vandenbroucke-Grauls
Journal:  FEMS Microbiol Lett       Date:  1996-08-15       Impact factor: 2.742

5.  Assessment of metronidazole susceptibility in Helicobacter pylori: statistical validation and error rate analysis of breakpoints determined by the disk diffusion test.

Authors:  S Chaves; M Gadanho; R Tenreiro; J Cabrita
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

6.  Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands.

Authors:  E J van der Wouden; A A van Zwet; G D Vosmaer; J A Oom; A de Jong; J H Kleibeuker
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

7.  Comparison of three methods for the determination of the sensitivity of Helicobacter pylori to metronidazole.

Authors:  A M Hirschl; M M Hirschl; M L Rotter
Journal:  J Antimicrob Chemother       Date:  1993-07       Impact factor: 5.790

8.  Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

Authors:  J Versalovic; D Shortridge; K Kibler; M V Griffy; J Beyer; R K Flamm; S K Tanaka; D Y Graham; M F Go
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

9.  Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance.

Authors:  A J DeCross; B J Marshall; R W McCallum; S R Hoffman; L J Barrett; R L Guerrant
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

10.  Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan.

Authors:  H Miyaji; T Azuma; S Ito; H Suto; Y Ito; Y Yamazaki; F Sato; M Hirai; M Kuriyama; T Kato; Y Kohli
Journal:  Aliment Pharmacol Ther       Date:  1997-12       Impact factor: 8.171

View more
  18 in total

Review 1.  How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.

Authors:  David Y Graham; Sun-Young Lee
Journal:  Gastroenterol Clin North Am       Date:  2015-06-19       Impact factor: 3.806

2.  Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Helicobacter pylori Infection in the Dominican Republic.

Authors:  Muhammad Miftahussurur; Modesto Cruz; Phawinee Subsomwong; José A Jiménez Abreu; Celso Hosking; Hiroyuki Nagashima; Junko Akada; Yoshio Yamaoka
Journal:  Am J Trop Med Hyg       Date:  2017-02-13       Impact factor: 2.345

3.  Frequency of antibiotic resistance in Helicobacter pylori strains isolated from the northern population of Iran.

Authors:  Amin Talebi Bezmin Abadi; Tarang Taghvaei; Ashraf Mohabbati Mobarez; Beth M Carpenter; D Scott Merrell
Journal:  J Microbiol       Date:  2011-12-28       Impact factor: 3.422

Review 4.  Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran.

Authors:  Marjan Mohammadi; Bahareh Attaran; Reza Malekzadeh; David Y Graham
Journal:  Dig Dis Sci       Date:  2017-06-02       Impact factor: 3.199

Review 5.  Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review.

Authors:  Reza Ghotaslou; Hamed Ebrahimzadeh Leylabadlo; Yalda Mohammadzadeh Asl
Journal:  World J Methodol       Date:  2015-09-26

Review 6.  Helicobacter pylori in Iran: A systematic review on the antibiotic resistance.

Authors:  Farzad Khademi; Farkhondeh Poursina; Elham Hosseini; Mojtaba Akbari; Hajieh Ghasemian Safaei
Journal:  Iran J Basic Med Sci       Date:  2015-01       Impact factor: 2.699

7.  Clarithromycin vs. Gemifloxacin in Quadruple Therapy Regimens for Empiric Primary Treatment of Helicobacter pylori Infection: A Randomized Clinical Trial.

Authors:  Mohsen Masoodi; Mahshid Talebi-Taher; Khadijeh Tabatabaie; Siamak Khaleghi; Amir-Hossein Faghihi; Shahram Agah; Reyhaneh Asadi
Journal:  Middle East J Dig Dis       Date:  2015-04

8.  Helicobacter pylori in Iran: A systematic review on the association of genotypes and gastroduodenal diseases.

Authors:  Elham Hosseini; Farkhondeh Poursina; Tom Van de Wiele; Hajieh Ghasemian Safaei; Peyman Adibi
Journal:  J Res Med Sci       Date:  2012-03       Impact factor: 1.852

9.  Validation of an in-house made rapid urease test kit against the commercial CLO-test in detecting Helicobacter pylori infection in the patients with gastric disorders.

Authors:  Maneli Amin Shahidi; Mohammad Reza Fattahi; Shohreh Farshad; Abdolvahab Alborzi
Journal:  J Res Med Sci       Date:  2012-03       Impact factor: 1.852

10.  Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran.

Authors:  Farzad Khademi; Jamshid Faghri; Farkhondeh Poursina; Bahram Nasr Esfahani; Sharareh Moghim; Hossein Fazeli; Peyman Adibi; Nasrin Mirzaei; Mojtaba Akbari; Hajieh Ghasemian Safaei
Journal:  J Res Med Sci       Date:  2013-12       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.